Clinical trial
Evaluation of Clonazepam and Paroxetine for Panic Disorder With Depression
NCT00031317 · National Institute of Mental Health (NIMH), NIH · Completed
Key facts
| NCT number | NCT00031317 |
|---|---|
| Title | Evaluation of Clonazepam and Paroxetine for Panic Disorder With Depression |
| Official title | Combined Treatment With A Benzodiazepine (Clonazepam) And A Selective Serotonin Reuptake Inhibitor (Paroxetine) For Rapid Treatment Of Panic Disorder With Depression |
| Lead sponsor | National Institute of Mental Health (NIMH), NIH |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Panic Disorder |
| Intervention type | Drug |
| Interventions | Paroxetine, Clozapine |
| Enrollment | 60 |
| Start date | Feb 1, 2002 |
| Completion | Jun 1, 2005 |
| First posted | Mar 1, 2002 |
| Last update posted | Mar 4, 2008 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: